全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2019 

Is there any relationship between mutation in CPS1 Gene and pregnancy loss?

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 deficiency (CPS1D), which usually presents as lethal hyperammonemia, is a rare autosomal recessive hereditary disease. Case: We report a case of a two-day-old female neonate with lethal hyperammonemia. The newborn infant was presented with hyperammonemia (34.7 ??g/ml; reference range 1.1–1.9). In Plasma amino acid analysis, there was a significant elevated levels of alanine (3,004 ??mol/L; reference range, 236–410 ??mol/L), glutamine (2,256 ??mol/L; reference range, 20–107 ??mol/L), asparagine (126 ??mol/L; reference range, 30–69 ??mol/L), glutamic acid (356 ??mol/L; reference range, 14–192 ??mol/L), aspartic acid (123 ??mol/L; reference range, 0–24 ??mol/L), and lysine (342 ??mol/L; reference range, 114–269 ??mol/L). We cannot diagnose the urea cycle disorder (UCD) CPS1D properly only based on the quantity of biochemical intermediary metabolites to exclude other UCDs with similar symptoms. Following next generation sequencing determined one homozygous mutation in CPS1 gene and also this mutation was determined in her parents. The identified mutation was c.2758G > C; p.Asp920His, in the 23 exon of CPS1. This novel homozygous mutation had not been reported previously. Conclusion: We applied whole exome sequencing successfully to diagnose the patient with CPS1D in a clinical setting. This result supports the clinical applicability of whole exome sequencing for cost-effective molecular diagnosis of UCDs

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133